Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study-Reference-Cited by-同舟云学术

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study

Published:2019-12-18 Issue: Volume:10 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Batista Rui,Vinagre João,Prazeres Hugo,Sampaio Cristina,Peralta Pedro,Conceição Paulo,Sismeiro Amílcar,Leão Ricardo,Gomes Andreia,Furriel Frederico,Oliveira Carlos,Torres João Nuno,Eufrásio Pedro,Azinhais Paulo,Almeida Fábio,Gonzalez Edwin Romero,Bidovanets Bohdan,Ecke Thorsten,Stinjs Pascal,Pascual Álvaro Serrano,Abdelmalek Rabehi,Villafruela Ainara,Beardo-Villar Pastora,Fidalgo Nuno,Öztürk Hakan,Gonzalez-Enguita Carmen,Monzo Juan,Lopes Tomé,Álvarez-Maestro Mario,Servan Patricia Parra,De La Cruz Santiago Moreno Perez,Perez Mario Pual Sanchez,Máximo Valdemar,Soares Paula

Publisher

Frontiers Media SA

Subject

Genetics (clinical),Genetics,Molecular Medicine

Reference83 articles.

1. KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas;Alexander;Lab. Invest.,2012

2. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer;Alfred Witjes;Eur. Urol.,2017

3. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome;Allory;Eur. Urol.,2014

4. EUA Guidelines on Non-muscle-invasive Bladder Cancer. Edn. presented at the EAU Annual Congress Copenhagen 2018;Babjuk,2018

5. Low- and high-grade bladder cancer appraisal via serum-based proteomics approach;Bansal;Clin. Chim. Acta,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma;Journal of Translational Medicine;2024-07-02

2. Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial;BJU International;2024-06-24

3. Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer;Molecular Oncology;2024-05-08

4. Use of Bladder Epicheck® in the follow-up of non-muscle-invasive Bladder cancer: A systematic literature review;Actas Urológicas Españolas (English Edition);2024-05

5. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17